Health News

A decade after scientists discovered that lab rats will rescue a fellow rat in distress, but not a rat they consider an outsider, new UC Berkeley research pinpoints the brain regions that drive rats to prioritize their nearest and dearest in times of crisis. It also suggests humans may share the same neural bias.

A new paper in JAMA Network Open, written by Berkeley Public Health Professor of Community Health Sciences Barbara Laraia, PhD, MPH, RD, Anil Aswani, PhD, associate professor of industrial engineering and operations research at UC Berkeley, and Matt Olfat, PhD, of Citadel LLC, finds that SNAP (the Supplemental Nutrition Assistance Program, commonly known as food stamps) recipients who had more available time were able to prepare higher quality meals, which reduced sodium consumption for them and their families.

In a May 2021 paper published in the journal AI & Society, clinical empathy expert and Berkeley Public Health bioethics professor Jodi Halpern, MD, PhD, posits that artificial intelligence (AI) cannot replace human empathy in the healthcare setting and that empathy is key to the successful treatment of patients.

Global land-use changes are creating “hot spots” favorable for bats that carry coronaviruses and where conditions are ripe for the diseases to jump from bats to humans, finds an analysis published this week by researchers at the University of California, Berkeley, the Politecnico di Milano (Polytechnic University of Milan) and Massey University of New Zealand.

One of the first major studies into the impact of COVID-19 on birth outcomes has found that pregnant people who are infected with the SARS-CoV-2 virus face significantly higher risk of severe maternal and newborn complications compared to those without the virus.

A study led by researchers at the Keck Graduate Institute (KGI), UC Berkeley and Vilnius University demonstrated new disease-detection capabilities of a hand-held device based on CRISPR gene editing technology, a development that could lead to faster, portable genetic testing for diagnostics and research.

A recent paper produced by The Liver Forums’ Pediatric Working Group and published in the journal Gastroenterology combs through the research to look for the best treatment— a “silver bullet”—to treat pediatric nonalcoholic diseases drug development.

A study by researchers at the UC Berkeley School of Public Health finds a link between exposure to formaldehyde and an increased risk of developing brain diseases such as brain cancer, Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis.

Mobilizing colleagues in the then-new Innovative Genome Institute (IGI) — a joint research collaboration between the University of California, Berkeley, and UC San Francisco — they sought to repair the single mutation that makes red blood cells warp and clog arteries, causing excruciating pain and often death.

Challenging the idea that older people with shorter life expectancies should rank lower in coronavirus immunization efforts, new UC Berkeley research shows that giving vaccine priority to those most at risk of dying from COVID-19 will save the maximum number of lives, and their potential or future years of life.

The University of California, San Francisco (UCSF) and UC Berkeley today announced a long-term research partnership with Genentech, a member of the Roche Group, and its parent company, Roche Holding AG, to speed the development of new therapeutics for debilitating brain diseases and disorders of the central nervous system (CNS), such as Alzheimer’s, Parkinson’s, Huntington’s, ALS and autism. UCSF and UC Berkeley will receive up to $53 million from Genentech over the course of the 10-year collaboration.

As California struggles to bring the deadly COVID-19 pandemic under control, the state’s Republican voters are far less likely to seek a vaccine and express less support for small businesses, health care workers and other at-risk workers, according to a new poll by UC Berkeley’s Institute of Governmental Studies (IGS).